Sector Focus

Healthcare & Pharmaceuticals

Sector Overview

Healthcare and pharmaceutical businesses work within a tightly regulated environment where commercial goals must be balanced against product safety, approvals, manufacturing and pricing requirements, even as biotechnology, digital health and data-driven healthcare open up new business models.

How We Advise

We advise pharmaceutical, biotechnology, medical device, healthcare and health-tech businesses on M&A, joint ventures, collaborations and fundraising, backed by sector-specific due diligence covering manufacturing facilities, licences and distribution arrangements. Regulatory compliance runs through nearly everything we do in this space, from product approvals and clinical trials to pricing, labelling, marketing and product recalls.

IP, Data & Healthcare Models

Intellectual property is fundamental to innovation in life sciences, and we advise on patents, trademarks, licensing and the commercialisation of pharmaceutical and medical technologies, alongside the data protection and cybersecurity considerations that come with handling patient data. We also support the growing shift toward telemedicine, e-pharmacy and other technology-enabled healthcare models, and advise on the manufacturing, supply and distribution arrangements that keep healthcare businesses running.